| Literature DB >> 36015116 |
Sergey V Gudkov1, Dmitriy A Serov1, Maxim E Astashev1, Anastasia A Semenova2, Andrey B Lisitsyn2.
Abstract
Antibiotic resistance in microorganisms is an important problem of modern medicine which can be solved by searching for antimicrobial preparations of the new generation. Nanoparticles (NPs) of metals and their oxides are the most promising candidates for the role of such preparations. In the last few years, the number of studies devoted to the antimicrobial properties of silver oxide NPs have been actively growing. Although the total number of such studies is still not very high, it is quickly increasing. Advantages of silver oxide NPs are the relative easiness of production, low cost, high antibacterial and antifungal activities and low cytotoxicity to eukaryotic cells. This review intends to provide readers with the latest information about the antimicrobial properties of silver oxide NPs: sensitive organisms, mechanisms of action on microorganisms and further prospects for improving the antimicrobial properties.Entities:
Keywords: bactericidal effect; bacteriostatic effect; fungicidal effect; fungistatic effect; green synthesis; mammalian cells cytotoxicity; nanoparticles; new materials development; silver oxide
Year: 2022 PMID: 36015116 PMCID: PMC9415021 DOI: 10.3390/ph15080968
Source DB: PubMed Journal: Pharmaceuticals (Basel) ISSN: 1424-8247
Antimicrobial properties of Polymers/Ag2O nanocomposites.
| № | Composition | Particle Size, nm | Microorganism Strains | Effect | MIC/MBC | Results | Reference |
|---|---|---|---|---|---|---|---|
| 1 | Ag2O NPs coating on glass | ~1500 | Bacteriostatic | 1.18 mg/mL | Coating of glass surfaces with Ag2O NPs significantly reduced the titers of the SARS-CoV-2 virus on the treated surface after 1 and 24 h. Ag2O NPs caused the death of all studied bacteria after 1 h. The activities against Gram-negative bacteria were more pronounced. | [ | |
| 2 | AgO NPs | ~170 |
| Bactericidal | 20 µg/mL | The bactericidal action of AgO NPs realized via disruption of the bacterial cell wall integrity detectable by K+ leakage from cells, increased Ag content in cell walls and TEM data. | [ |
| 3 | Ag2O NPs in Ag2O NPs/Ag sensor for detection of 4-nitrotoluene | 80–90 |
| Bacteriostatic | 100 µg/mL | Ag2O NPs showed bacteriostatic effect against both studied bacteria. The antimicrobial effect against Gram-positive bacteria is much higher. | [ |
| 4 | Ag2O NPs synthesized in | 500–1000 | Bacteriostatic | ~23.2 mg/mL * | Ag2O NPs inhibited growth of all studied antibiotic-resistant | [ | |
| 5 | Ag2O NPs synthesized in | 110–120 |
| Bacteriostatic | 28.125–112.5 µg/mL | Antimicrobial activity significantly varied depending on the species of microorganism. Ag2O NPs decreased viability of HepG2 cell line and HUH-7 cancer cells at concentrations above 9 µg/mL. | [ |
| 6 | Ag2O NPs synthesized in | 1–100 |
| Bacteriostatic | 25 µg/mL | Ag2O NPs/ | [ |
| 7 | Ag2O NPs synthesized in | 38–86 |
| Bacteriostatic | 0.125 µg/mL | Bacteriostatic action against Gram-negative bacteria was more pronounced. The mechanism of bacteriostatic action is a photocatalysis. | [ |
| 8 | Ag2O NPs synthesized in | 8–40 |
| Bacteriostatic | ~100 µg/mL | Ag2O NPs/ | [ |
| 9 | Natural hydrogel from | 20–40 | Bacteriostatic | 12.5/25 µg/mL | Maximal antimicrobial effect of nanocomposite was observed at 200 μg/mL polyphenol concentrations. | [ | |
| 10 | Ag2O NPs mixed with chitosan solution (1% | ~5 | № | ~5.8 mg/mL | Chitosan/Ag2O NPs inhibited growth of all studied bacteria. | [ | |
| 11 | Chitosan/Ag2O NPs suspension | 10–20 | Bacteriostatic | 2 µg/mL | Treating of cotton fibers by chitosan/Ag2O NPs suspension reduced Gram-negative and Gram-positive bacterial growth up to 100%. | [ | |
| 12 | Chitosan/Ag2O NPs suspension | 100–200 | Bacteriostatic | 2 µg/mL | Treating of cotton fibers by chitosan/Ag2O NPs suspension reduced bacterial growth and did not change coefficient of friction of the treated fabric. | [ | |
| 13 | Polyethersulfone (PES)/cellulose acetate (CA)/Ag2O NPs nanocomposite and Cu·PES/CA/Ag2O NP membranes | 20–100 |
| Bacteriostatic | 8 mg/mL | PES/CA/Ag2O NPs and Cu·PES/CA/Ag2O NPs composites inhibited bacterial growth up to 20–30 and 80–90%, respectively, during 12–24 h. | [ |
| 14 | Aspirin conjugated Ag2O NPs coated by polyvinyl alcohol (PVA) or starch | - | Bacteriostatic, | 10 µg/mL | Aspirin conjugated Ag2O NPs inhibited microbial growth above 40%. Coating of Aspirin/Ag2O NP by PVA or starch increased percent inhibition to 60%. | [ | |
| 15 | Bayerite underpinned Ag2O/Ag NPs incorporated PMMA films | - | Bacteriostatic | 0.034 and 0.017 mg/mL | Bayerite Ag2O/Ag nanohybrid demonstrated antibacterial and antibiofilm activities against tested standard strains and clinical isolates. | [ | |
| 16 | Graphene oxide (GO)/Ag2O NPs composite | 36.3–49.9 | Bacteriostatic | 20 mg/mL | GO/Ag2O NPs composite was more effective against Gram-negative bacteria. Increasing of GO wt% improved bacteriostatic activity of nanocomposite. | [ | |
| 17 | Polyethylene terephthalate (PET)/Ag2O NPs composite | 50–500 |
| Bacteriostatic | - | PET/Ag2O NPs inhibited bacterial growth. Bacteriostatic was same in PET/Ag2O NPs samples obtained at different pH. | [ |
| 18 | Ag2O-TiO2 NPs | 50–150 |
| Bacteriostatic | 1.5 mg/mL | The nanocomposite increased photocatalytic degradation of aniline and inhibit | [ |
| 19 | Ag2O-TiO2 NPs immobilized on doped by cellulose | 10 ± 5 | - | Proposed bactericidal by photocatalysis | - | The nanocomposite increased photocatalytic degradation of methylene blue, Rhodamine B and norfloxacin under the irradiation of UV light. | [ |
| 20 | Ag2O NPs synthesized with culture | 28–38 | Bactericidal | 20 µg/mL | Ag2O NPs showed significant bactericidal and antibiofilm activity through bacterial binding. Ag2O NPs had cytotoxic action versus A549 cancer cell line. | [ | |
| 21 | Precipitated Ag2O NPs | 30 |
| Bacteriostatic | 30 µg/mL | Ag2O NPs almost completely inhibited the growth of | [ |
| 22 | Green synthesized Ag2O NPs with | ~39 | Bacteriostatic | 23.1 µg/mL * | Ag2O NPs showed comparable bacteriostatic activity against Gram-positive and Gram-negative bacteria | [ | |
| 23 | Borosiloxane Ag2O NPs nanocomposite | 65 |
| Bacteriostatic | 1 µg/mL | Ag2O NPs doped into a borosiloxane matrix pronounced bacteriostatic and bactericidal properties via generation of ROS but did not have cytotoxicity against eukaryotic cells. | [ |
| 24 | PLGA and Ag2O NPs nanocomposite | 35 |
| Bacteriostatic | 1 µg/mL | Ag2O NPs increased generation of H2O2 and OH-radicals, which can lead to damage to bacterial DNA and proteins but does not have cytotoxicity against mammalian cells. | [ |
| 25 | Ag2O NPs in | 10–40 | Bacteriostatic | 0.16 µg/mL | “Green synthesized” Ag2O NPs shower a weak bacteriostatic effect against both Gram-positive and Gram-negative bacteria. Ag2O NPs, but not | [ | |
| 26 | ZrO2-Ag2O NPs | 14–42 | Bacteriostatic | 0.1 µg/mL | ZrO2 NPs enhanced the bacteriostatic effect of Ag2O NPs. The bacteriostatic effect of both Ag2O NPs and ZrO2-Ag2O depends more on the bacterial species than on belonging to Gram-positive and Gram-negative bacteria. | [ | |
| 27 | Ag2O/Ag NPs with | 6–8 |
| Bacteriostatic | 50 µg/mL | The antibacterial action was realized via increased ROS generation | [ |
| 28 | Ag2O NPs conjugated with starch in different proportions | 30–110 |
| Bacteriostatic | 100 µg/mL | The bacteriostatic properties of starch-conjugated Ag2O NPs enhanced with increasing size and starch/Ag2O NPs ratio. | [ |
| 29 | Ag2O NPs synthesized by precipitation method | 16 | Bacteriostatic | 60 µg/mL | Ag2O NPs starting at 60 µg/mL inhibited bacterial growth. CFU of | [ | |
| 30 | Ag and Ag2O NPs synthesized by reduction of [Ag(NH3)2]+ and conjugated by different sugars | 25 | Bacteriostatic | 0.68 µg/mL | Ag and Ag2O NPs showed more pronounced antimicrobial activity against Gram-negative bacteria. The addition of glucose and lactose to the NP synthesis medium significantly enhanced the antimicrobial effect of NPs. | [ | |
| 31 | Ag2O and Ag NPs synthesized using | 42.7 | Bacteriostatic | 100 µg/mL/ | Ag2O NPs equally inhibited the growth of the studied oral pathogens, regardless of Gram staining. | [ | |
| 32 | Ag2O NPs synthesized using | 40 |
| Bacteriostatic | 100 µg/mL | Ag2O NPs/ | [ |
| 33 | Ag2O NPs conjugated with moxifloxacin | 49.76 |
| Bacteriostatic | 40–60 µg/mL * | The conjugation of Ag2O NPs with moxifloxacin increased the area of the zone of inhibition for all stufied microorganisms by 2–3 times compared to non-conjugated Ag2O NPs. The photocatalytic action is proposed mechanism of antimicrobial action. | [ |
| 34 | Ag2O NPs conjugated with silk fibroin (Ag2O-SF) | 15 |
| Bacteriostatic | 115.9 µg/mL * | The conjugation of Ag2O NPs with silk fibroin enhances the bacteriostatic properties of Ag2O NPs | [ |
| 35 | Ag2O NPs composite with | 20 |
| Bacteriostatic | 0.1 mg/mL | Ag2O NPs/ | [ |
| 36 | Ag/Ag2O NPs with leaf extract of | 8.2–20.5 |
| Bacteriostatic | 25–75 µg/mL | Ag2O NPs/ | [ |
| 37 | Ag2O NPs with | 66 |
| Bacteriostatic | ~4.2 mg/mL * | Ag2O NPs/ | [ |
| 38 | Highly or poorly oxidized AgO/Ag/SnO2 | 10–20 | Bacteriostatic | 0.4 µg/mL * | Nanocomposites with highly oxidized AgO NPs had a more pronounced bacteriostatic effect, and composites of NPs with weakly oxidized AgO NPs had a more pronounced fungistatic effects. | [ | |
| 39 | Ag2O NPs | 17.45 |
| Bacteriostatic | 5 µg/mL | Ag2O NPs had a more pronounced antibacterial effect against Gram-negative bacteria compared to Gram-positive ones. The mechanism of antibacterial action is inhibition of ATP synthesis. | [ |
| 40 | Ag2O/Ag NPs synthesized in extract | 10–60 |
| Bacteriostatic | 10 µg/mL | Ag2O/Ag NPs/ | [ |
| 41 | SrTiO3 nanotubes (NTs) embedded with Ag2O NTs | 10×80 |
| Bactericidal | ― | SrTiO3 NTs/Ag2O NPs inhibited the growth of | [ |
| 42 | Ag2O NPs/Ti NBs | 3–10 |
| Bactericidal | 100 µg/mL | Ag2O/Ti NPs reduced the number of | [ |
| 43 | Ag2O NPs/Ti NBs | 5–30 |
| Bactericidal | 1.27 µg/mL | Ag2O NPs/Ti NBs killed 100% during 14–21 days. The release of Ag+ is the mechanism of its antibacterial action. | [ |
| 44 | Ag2O/Ag NPs synthesized in | 7–10 |
| Bacteriostatic | <116 µg/mL * | The antimicrobial effect against Gram-positive bacteria is more pronounced than against Gram-negative ones. | [ |
| 45 | Ag2O NPs with polyhedral shape | 400–700 |
| Bactericidal | 10 µg/mL | The antimicrobial effect of cubic NPs is two times higher than that of octahedral NPs. | [ |
| 46 | H2Ti3O7•2H2O/Ag2O NPs nanocomposites | 10–40 |
| Bacteriostatic | 25 µg/mL | The addition of Ag2O NPs to H2Ti3O7·2H2O increased the antimicrobial properties. The antibacterial action was equal against Gram-negative and Gram-positive bacteria. | [ |
| 47 | Ag/AgO/Ag2O NPs/ | 2–4 |
| Bacteriostatic | 50 mg/mL | Ag/AgO/Ag2O NPs improved antimicrobial properties of resulting composite. The bacteriostatic effect against Gram-positive or Gram-negative bacteria was comparable. | [ |
| 48 | Ceftriaxone/Ag2O NPs | 35.54 |
| Bacteriostatic | 10 µg/mL | The antimicrobial activities of ceftriaxone and Ag2O NPs, assessed by zones of inhibition, were summarized. | [ |
| 49 | Ag/Ag2O NPs synthesized in | ~10.4 |
| Bacteriostatic | <12 µg/mL * | Antibacterial and antifungal activity significantly depended on the species of microorganisms. Interspecies differences in antibacterial action are more pronounced than differences between Gram-positive and Gram-negative bacteria. | [ |
| 50 | Ag/Ag2O NPs synthesized in cell-free extract of | 20 | Bacteriostatic | 125 µg/mL | Ag/Ag2O NPs had bacteriostatic effect and enhanced the antibacterial effect of 800 µg/mL carbenicillin. | [ | |
| 51 | Ag/Ag2O NPs synthesized in dead yeast | 11 | Bacteriostatic | 2 µg/mL | Ag/Ag2O NPs/ | [ | |
| 52 | Ag/Ag2O NPs synthesized in silver | 6–38 |
| Bacteriostatic | ― | The most bacteriostatic effect was shown by Ag2O NPs with smallest size. This NP were obtained at plasma power of 1250 W. | [ |
| 53 | Ag2O NPs and nano-rod complex (1), [Ag (3-bpdh)(NO3)]n | 45–60 |
| Bacteriostatic | 6.25–25 µg/mL | Ag2O NPs were equally effective against Gram-positive and Gram-negative bacteria. Least bacteriostatic effect against | [ |
| 54 | Ag2O NPs mixed with | 11–12 |
| Bacteriostatic | 100 µg/mL | Ag2O NPs/ | [ |
| 55 | Ag/Ag2O NPs synthesized in | 25–26 |
| Bacteriostatic | 500 µg/mL | Ag2O NPs/ | [ |
| 56 | Ag2O NPs synthesized in | 8–10 |
| Bacteriostatic | 10 µg/mL | Ag2O NPs/ | [ |
| 57 | Ag2O NPs with addition of 1–9% Sr | 35.7–48.4 |
| Bacteriostatic | ~100 µg/mL | 3% Sr/Ag2O NPs showed maximal bacteriostatic and fungistatic activities. Antibacterial activity did not depend on species. Antifungal activity was species dependent. | [ |
| 58 | Ag2O/Ag NPs synthesized by precipitation of AgNO3 in N-propanol | 19–60 |
| Bacteriostatic | 5 µg/mL | Ag2O/Ag NPs inhibited growth of all studied microbes, had anti-biofilm activity. Mechanism of toxicity is Ag+ releasing. Ag2O/Ag NPs showed less cytotoxicity against Vero cell line than equal amount of AgNO3. | [ |
*—concentration is not directly indicated in article in µg/mL and is calculated based on description in Materials and Method sections. Original data are shown in brackets.
Figure 1Results of the data analysis regarding antimicrobial properties of Ag2O NPs: (a) microorganisms, against which the inhibitory activity of NPs was shown most often; (b) dependence of MIC against E. coli on NP sizes. R—value of the correlation coefficient; (c) dependence of MIC on a method of NP generation. *—p < 0.05, a significant difference from the precipitation variant using the Mann–Whitney test. Each dot represents a mention in one publication. The data are presented as medians, percentiles (10, 25, 75 and 90%).
Figure 2Schematic representation of mechanisms of the antibacterial activity of Ag2O NPs (explanations are given in the text).